Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01188551 · ClinicalTrials.gov registry record · Phase 2
Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement
A Phase 2 study of Chronic Otitis Media, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT01188551 is a Phase 2 study of Chronic Otitis Media that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01188551, a Phase 2 study of Chronic Otitis Media, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to compare intranasal dexmedetomidine to intranasal fentanyl following anesthesia induction in patients undergoing myringotomy and placement of pressure equalization (PE) tubes in providing analgesia and smoothing emergence from general anesthesia.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Fentanyl
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01188551
The ClinicalTrials.gov registry entry for NCT01188551 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Otitis Media appearing as the primary indexed condition, and to 3 interventions - of which Midazolam is the first listed.
NCT01188551 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01188551 about?
NCT01188551 is a clinical study titled "Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement". This is a study to compare intranasal dexmedetomidine to intranasal fentanyl following anesthesia induction in patients undergoing myringotomy and placement of pressure equalization (PE) tubes in providing analgesia and smoothing emergence from general anesthesia.
What is the current status of trial NCT01188551?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2011-01. Estimated completion is 2012-04.
What conditions does trial NCT01188551 study?
This clinical trial studies the following conditions: Chronic Otitis Media.
What interventions are being tested in trial NCT01188551?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT01188551?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01188551 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.